Hossein Alizadeh

Dr. Hossein Alizadeh serves as the Technical Director for the Photonics Center, where he oversees the overall strategic planning for the center’s core facilities and manages the acquisition, implementation, and maintenance of the Photonics Center’s technical instruments and facilities. Dr. Alizadeh supervises lab managers Paul Mak, Dr. Alexey Nikiforov, and Dr. Arthur Shih, and collaborates […]

Thomas Bifano

Dr. Thomas Bifano directs the Boston University Photonics Center (BUPC), a core facility and academic center of excellence focusing on optics and photonics research in academia and industry. He leads BUPC programs for education, scholarly research and development of advanced photonics device prototypes for commercial and military applications. His research focuses on design, manufacturing, and […]

Ji-Xin Cheng

Dr. Cheng’s research interests include neurophotonics, medical photonics, molecular spectroscopic imaging technologies, label-free microscopy, cancer metabolism, and photonics for infectious diseases. With a focus on the medical application of photonics, Dr. Cheng hopes to advance the field with his research and innovative technologies.

Cara Ellis McCarthy

As Executive Director, Cara Ellis McCarthy develops, manages, and executes strategies and programs to advance the mission of the Center, including management of financial operations, pre-and post-award grant activity; human resource functions and staff supervision; oversight of communications and event planning; Photonics Center building resources and operations; technical and lab management team, and the safe […]

Björn Reinhard

The main research areas in the Reinhard Laboratory are Bioplasmonics, Nano-Bio Interface and Materials Science. We develop plasmonic nano-scale probes to probe, control, and reverse-engineer biological functionality. We are particularly interested in elucidating the fundamental principles that govern cell-nanoparticle interactions, spatial regulation of signaling, and biomimetic energy harvesting systems.

Darren Roblyer

The Roblyer research group develops new label free imaging modalities to diagnose disease and monitor therapies. A main thrust of the lab is development of new wearable and handheld technologies that can provide earlier assessments of therapy effectiveness for cancer, cardiovascular diseases, kidney disease, and others.